Matthew Strobeck's most recent trade in QuidelOrtho Corporation was a trade of 6,829 Restricted Stock Units (Equity Grant) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,829 | 6,829 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,929 | 17,775 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 4,929 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 2,416 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 2,416 | 12,846 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,929 | 4,929 | - | - | Restricted Stock Units (Equity Grant) | |
| Accelerate Diagnostics Inc | Matthew Strobeck | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 100,000 | 100,000 | - | - | Common Stock Warrants (right to buy) | |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 100,000 | 120,682 (0%) | 0% | - | Common Stock | |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 236,842 | 236,842 | - | - | Employee Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 2,248 | 10,430 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 2,248 | 0 | - | - | Restricted Stock Units (Equity Grant) | |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2023 | 78,947 | 78,947 | - | - | Employee Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 2,416 | 2,416 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 427 | 8,097 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 427 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 85 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85 | 8,182 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2023 | 875 | 7,408 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2023 | 875 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2023 | 262 | 7,670 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2023 | 262 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 2,248 | 2,248 | - | - | Restricted Stock Units (Equity Grant) | |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 75,949 | 75,949 | - | - | Employee Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 38,145 | 0 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 38,145 | 38,145 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 16,630 | 16,630 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 16,630 | 0 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 6,533 | 6,533 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 6,533 | 0 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 875 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 875 | 875 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 427 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 427 | 427 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 262 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 262 | 262 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 259 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 259 | 259 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 85 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 85 | 85 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 30 Sep 2021 | 19,531 | 206,828 (0%) | 0% | 7.7 | 149,998 | Common Stock |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 35,168 | 35,168 | - | - | Stock Option (right to buy) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,624 | 1,624 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 427 | 427 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 85 | 85 | - | - | Restricted Stock Units (Premium) | |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 09 Apr 2021 | 19,531 | 187,297 (0%) | 0% | 7.7 | 149,998 | Common Stock |
| Accelerate Diagnostics Inc | Strobeck Matthew | Director | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 19 Feb 2021 | 19,531 | 167,766 (0%) | 0% | 7.7 | 149,998 | Common Stock |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Purchase of securities on an exchange or from another person at price $ 166.60 per share. | 02 Sep 2020 | 7,000 | 37,445 (0%) | 0% | 166.6 | 1,166,190 | Common Stock |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Purchase of securities on an exchange or from another person at price $ 155.64 per share. | 02 Sep 2020 | 350 | 38,095 (0%) | 0% | 155.6 | 54,474 | Common Stock |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Purchase of securities on an exchange or from another person at price $ 167.74 per share. | 02 Sep 2020 | 300 | 37,745 (0%) | 0% | 167.7 | 50,321 | Common Stock |
| QuidelOrtho Corporation | Strobeck Matthew | Director | Purchase of securities on an exchange or from another person at price $ 155.60 per share. | 02 Sep 2020 | 50 | 38,145 (0%) | 0% | 155.6 | 7,780 | Common Stock |